77 results
424B5
VANI
Vivani Medical Inc
5 Mar 24
Prospectus supplement for primary offering
11:31am
to a wide range of causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease and eye injury. Orion is intended to convert images … are legally blind from eye trauma, optic nerve disease and injury, diabetic retinopathy, retinitis pigmentosa, age related macular degeneration, glaucoma
DEFR14A
VANI
Vivani Medical Inc
1 May 23
Revised proxy
4:49pm
a director’s duties is, or should be, aware of a risk of serious injury to the corporation or its stockholders;
(v) Acts or omissions
8-K
EX-10.1
jre6b6
28 Nov 22
Entry into a Material Definitive Agreement
5:29pm
S-8
znj3faahrra aic73a
2 Sep 22
Registration of securities for employees
5:00pm
DEFA14A
naovviwnyvsckpmlya
18 Jul 22
Additional proxy soliciting materials
8:47am
425
EX-99.1
b4wif2tv
18 Jul 22
Business combination disclosure
8:45am
8-K
EX-99.1
d2zhr0g7f
18 Jul 22
Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study
8:44am
DEFM14A
xp87m zcsg19
24 Jun 22
Proxy related to merger
4:44pm
424B3
en0fv
24 Jun 22
Prospectus supplement
4:38pm
S-4/A
epa77jyg13ig8um 7h9
16 Jun 22
Registration of securities issued in business combination transactions (amended)
5:23pm
S-4
0td2qlgk8p
13 May 22
Registration of securities issued in business combination transactions
5:10pm
425
EX-99.1
mhq3y cyjqw7cn5zswag
8 Feb 22
Business combination disclosure
12:00am